Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma

Authors
Publication date
1 January 2018
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Institutional Research Information System University of Turin

    redirect
    oaioai:iris.unito.it:2318/1661910
    Last time updated on 18/04/2020